by will | Oct 29, 2025
BioPharma Monocyte reprogramming for Rheumatoid Arthritis Rheumatoid arthritis is an autoimmune disease that leads to the progressive destruction of joints. The disease is not curable and requires life-long treatment. Queen Mary researchers recently uncovered a novel...
by will | Oct 29, 2025
BioPharma Predicting sensitivity to disease-modifying antirheumatic drugs with pro-resolving mediators Rheumatoid arthritis is an autoimmune disease that leads to the progressive destruction of joints. The disease is not curable and requires life-long treatment. It is...
by will | Jul 29, 2025
BioPharma Predicting patient response to arthritis treatment using machine learning 1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body’s immune system attacking its own...
by will | Jan 16, 2024
BioPharma Restorative treatments for osteoarthritis There’s no cure for osteoarthritis. Current treatment for this debilitating joint disease involves managing symptoms and replacing joints. Professor Francesco Dell’Accio and his team have invented three novel and...
